BRCA1 and ovarian cancer: We first analyzed the Australian Ovarian Cancer Study (AOCS) cohort which comprises 80 primary OvCas (24), including 32 TDP type 1 cancers, 30 of which exhibit some form of BRCA1 abrogation (Fig. 5A and fig.